A Democratic bill with no cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, titled the "Protecting Americans from Unsafe Drugs Act of 2026," aims to amend the Federal Food, Drug, and Cosmetic Act. The primary goal is to expand specific authorities regarding the recall of drugs. It changes the scope of current authorities that apply to controlled substances so that they apply to all drugs. This includes changes to orders to cease distribution and recall procedures. The bill also updates regulations regarding imports and exports.
Yes· 3 of 5
- Scored +4
Does this give the federal government more power?
The bill expands the regulatory authority of the FDA to order the cessation of distribution and recalls for all drugs rather than just controlled substances.
- Scored +3
Does this make health care easier to get in general?
By expanding recall authority to all drugs, the bill enhances consumer safety regarding medication availability and quality.
- Scored +2
Does this make the country readier for the next outbreak?
Expanding recall authority to all drugs improves the regulatory response capabilities during potential public health crises.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
- Expanded Recall Authority: The bill expands authorities that were previously limited to controlled substances to apply to all drugs under Section 2(a). This change to the section heading and the replacement of "controlled substance" with "drug" means the authority to order a cessation of distribution and a recall can now apply to a broader range of medications.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — By expanding recall authority to all drugs, the bill enhances consumer safety regarding medication availability and quality. Does this make the country readier for the next outbreak? — Expanding recall authority to all drugs improves the regulatory response capabilities during potential public health crises.
- Governance And Ideology
- Does this give the federal government more power? — The bill expands the regulatory authority of the FDA to order the cessation of distribution and recalls for all drugs rather than just controlled substances.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — Expanded drug recall powers provide increased safety protections for all consumers, including low-income households. Would people in cities be better off under this? — The expansion of drug safety oversight benefits all residents through improved medication safety standards.
- 3/18/2026
- Referred to the House Committee on Energy and Commerce.
- Introduced in House